Quick Summary
Poria (Wolfiporia extensa) is a traditional medicinal mushroom used in various botanical formulations primarily in East Asian medicine. It has been studied preclinically for multiple conditions including liver fibrosis and diabetes, and is a component of some traditional herbal formulas. However, direct clinical evidence on Poria alone is lacking, and current research often involves its use within complex herbal preparations.
What is it?
Poria, also known as Wolfiporia extensa, is a fungus traditionally used in East Asian herbal medicine. It is commonly included in multi-herb formulas rather than administered as a single agent. The mushroom is valued for its purported health-promoting properties and is frequently incorporated into botanical blends aimed at supporting metabolic and liver health.
Traditional Uses
Traditionally, Poria has been used in Chinese medicine for supporting digestive function, promoting diuresis, calming the mind, and enhancing overall vitality. It is often included in formulas designed to treat conditions associated with fluid retention, metabolic dysfunction, and chronic illness.
Active Compounds
Poria contains a variety of bioactive components, including polysaccharides, triterpenoids, and other secondary metabolites that may contribute to its biological effects. These compounds are believed to have antioxidant, anti-inflammatory, and metabolic-regulating properties, although detailed profiling of these constituents is ongoing.
Potential Benefits with Evidence Levels
- Liver Fibrosis: Preclinical and mixed (clinical and preclinical in botanicals). Botanical-based treatments containing Poria have demonstrated promising therapeutic effects in liver fibrosis models and traditional medicine formulas (Chen et al., 2025). No direct clinical trials of Poria alone have been reported.
- Type 2 Diabetes Mellitus (T2DM): Preclinical and traditional use context. Traditional Chinese Medicine compounds containing Poria have shown potential in improving T2DM-related metabolic dysfunction via multiple mechanisms in preclinical research (Wang et al., 2025; Zhao et al., 2025). Clinical trials specific to Poria as a single agent are not identified.
Side Effects
No serious adverse effects or toxicity have been reported in the literature for Poria or formulations containing it. Adverse effects are not systematically documented, and no significant adverse events have been noted in meta-analyses of multi-herbal formulas that include Poria.
Drug Interactions
No specific documented drug interactions involving Poria have been identified. Due to its use in complex traditional formulas, there may be potential interactions with conventional medicines, but these have not been systematically studied or confirmed.
Who Should Avoid It
No explicit contraindications for Poria have been reported based on available clinical or preclinical data. However, individuals who are pregnant, breastfeeding, or have known sensitivities to mushrooms or herbal products should exercise caution and consult a healthcare provider prior to use, given the limited safety information.
Evidence Limitations
- Most research on Poria is conducted in the context of multi-herb formulas, limiting the ability to attribute specific effects to Poria alone.
- There is a lack of randomized controlled trials or high-quality clinical studies evaluating Poria as a single agent for any condition.
- Preclinical findings cannot be directly extrapolated to clinical efficacy or safety.
- Safety data specific to Poria remain sparse and incompletely reported.
- Variability in methodological quality and reporting of botanical studies reduces consistency and comparability of results.
References
- Chen S, Wu Z, Zhang J, Lin Y, Xie J, Yin D, Zhu Y. (2025). Research and application of medicines for treating liver fibrosis: current status and prospects. Europe PMC. https://pubmed.ncbi.nlm.nih.gov/40703362/. doi: 10.3389/fphar.2025.1582258.
- Wang M, Yang Q, Li Y, Zhao Y, Zou J, Luan F, Peng X, Huang Z, Liu F. (2025). Therapeutic potential of traditional Chinese medicine and mechanisms for the treatment of type 2 diabetes mellitus. Europe PMC. https://pubmed.ncbi.nlm.nih.gov/41044789/. doi: 10.1186/s13020-025-01222-x.
- Zhao YL, Liao JB, Pang PP, Li JY, Su SC, Shao MQ, Wen WB, Xu FR. (2025). Pharmacological advances in multi-targeted strategies for type 2 diabetes mellitus: a systematic perspective based on traditional Chinese medicine. Europe PMC. https://pubmed.ncbi.nlm.nih.gov/41799384/. doi: 10.3389/fphar.2025.1732134.
- Kim G, Lee HG, Ha WJ, Kwon S. (2024). Current Utilization and Research Status of Herbal Medicine Sipjeondaebotang for Anemia: A Scoping Review. Europe PMC. https://pubmed.ncbi.nlm.nih.gov/39338353/. doi: 10.3390/ph17091192.
- Lin CT, Wu LY, Tsai FS. (2024). Predictive Analysis of Yi-Gai-San’s Multifaceted Mechanisms for Tremor-dominant Parkinson’s Disease via Network Pharmacology and Molecular Docking Validation. Europe PMC. https://pubmed.ncbi.nlm.nih.gov/38879763/. doi: 10.2174/0109298673291838240311075415.
Last Reviewed
April 2024
Informational Disclaimer: This page is for informational purposes only and does not constitute medical advice. The potential health effects of Poria are based on preclinical studies and limited traditional use. Consult a qualified healthcare professional before starting any herbal supplement, especially if you are pregnant, nursing, have existing medical conditions, or are taking medications.